Key result
Furong Tongmai capsule reduces aortic plaque area and improves lipid profiles in atherosclerotic mice.
Why the study?
The mechanisms by which Furong Tongmai Capsule ameliorates atherosclerosis through gut microbiota, arachidonic acid metabolism, and macrophage polarization remain to be elucidated.
Does Furong Tongmai capsule ameliorate atherosclerosis plaque burden, dyslipidemia, and vascular inflammation in high-fat diet-fed ApoE-/- mice by modulating gut microbiota, arachidonic acid metabolism, and macrophage polarization?
Does Furong Tongmai capsule ameliorate atherosclerosis plaque burden, dyslipidemia, and vascular inflammation in high-fat diet-fed ApoE-/- mice by modulating gut microbiota, arachidonic acid metabolism, and macrophage polarization?
Answers are grounded in this paper and cite their sources.
This preclinical murine study provides associative evidence that the traditional Chinese medicine Furong Tongmai capsule attenuates atherosclerosis in ApoE-/- mice alongside alterations in gut microbiota, arachidonic acid metabolism, and macrophage M2 polarization.
mice fed a high-fat diet, FRTM administration improved serum lipid profiles by reducing total cholesterol, triglycerides and low-density lipoprotein cholesterol and increasing high-density lipoprotein cholesterol. FRTM also attenuated aortic lesion formation, reduced pro-inflammatory cytokines (IL-6, IL-1β and TNF-α), and improved oxidative stress indices. 16S rRNA sequencing showed that FRTM reshaped the gut microbiota, increasing beneficial taxa such as Lactobacillus and Bifidobacterium while decreasing Turicibacter. Functional prediction and untargeted serum metabolomics both suggested that arachidonic acid metabolism was a key pathway affected by FRTM. Furthermore, FRTM was associated with increased p-PPARγ and EP4 expression, decreased p-P65, and increased p-STAT3/STAT3, accompanied by downregulation of M1 markers (iNOS/Nos2) and upregulation of M2 markers (CD206 and ARG1). Faecal microbiota transplantation from FRTM-treated donors partially recapitulated the anti-atherosclerotic and anti-inflammatory effects. Overall, these findings suggest that FRTM may ameliorate AS in a murine model by modulating gut microbiota, arachidonic acid metabolism and macrophage polarization; however, further functional studies are needed to establish causality and assess translational relevance.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2026) studied Atherosclerosis (murine model) (n=80). Furong Tongmai capsule (FRTM) vs. Oral saline (0.1 mL/10 g) in control and model groups, or atorvastatin (10 mg/kg/day) was evaluated on Relative aortic atherosclerotic plaque lesion area (Oil Red O staining) and serum lipid profile (TC, TG, LDL-C, HDL-C) (p=<0.05). Furong Tongmai capsule reduced aortic plaque area and improved serum lipid profiles compared to untreated model controls in ApoE-/- mice with high-fat diet-induced atherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: